SEC Form 4 · accession 0001209191-15-011606
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Brege
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 10, 2015 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $27.50 | Feb 5, 2015 | A | 20,000 | A | — | Jan 26, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option shares shall vest as follows: 1/36th of the shares subject to such option shall vest each month after January 27, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date.
- F2Not applicable.